| Charles River Laboratories International, Inc. (Charles River) is a global provider of solutions that advance the drug discovery and development process, including research models and associated services, and outsourced preclinical services. It provides the animal research models required in research and development for drugs, devices and therapies. Charles River's customer base includes global pharmaceutical companies, a range of biotechnology companies, as well as government agencies, hospitals and academic institutions worldwide. It operates approximately 60 facilities, including its production and warehousing facilities, in 15 countries worldwide. The Company has two segments: Research Models and Services and Preclinical Services, which includes Phase I clinical services. In September 2008, Charles River announced that it has completed the acquisition of privately held NewLab BioQuality AG. In September 2008, Charles River acquired Molecular Imaging Research, Inc. |
